NW-301 TCR-T

· Peking University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NW-301 TCR-T, covering 2025-05-04 to 2025-05-04. Get the full timeline:

Most recent: Clinical Trial Update: NW-301 TCR-T in Patients With Advanced Solid Tumor [Phase 1]